Email not displaying correctly? View it in your browser.

Continuing the tradition of this meeting series, ASBE V will present the latest advances in Applied Synthetic Biology research. Covering fundamental and technological discoveries and applications of different biological systems, ASBE V will bring together key partners from both academia and industry. Supported by prestigious keynote speakers such as Jay Keasling, Claudia Vickers, Marileen Dogterom and John van der Oost, ASBE V warmly welcomes early carrier scientists with talks selected from submitted abstracts. Discounts for early career scientists and grants are available upon application. Join ASBE V to share your research and follow the most recent advances in the flourishing Synthetic Biology community!

Due to the continued spread of the Coronavirus (COVID-19), the registration and abstract submission for Microbial Stress meeting in Rome have been suspended. We will soon announce further information.

Due to the continued spread of the Coronavirus (COVID-19), the Organising Committee of the Joint ECB2020 and IBS 2020 Congress have taken the decision to postpone this year's Congress. The ECB-IBS 2020 Congress will be moved to the 9-12 May 2021 and will still be held at the MECC in Maastricht, The Netherlands.

There are still slots available for invited short talks. Submit your abstract and present your research at the ECB-IBS 2021 Congress.

In these exceptional and unprecedented times, many companies and organizations are eagerly working to advance the development of a vaccine in the context of the current COVID-19 crisis.

New bioprocess technologies such as single-use equipment and process automation open up novel possibilities for quality control and validation. This is especially important in GMP regulated environments such as in the development and manufacturing of new influence vaccines. When facing a pandemic outbreak, the need to smoothly develop new processes and quickly scale-up to clinical production volumes is key to efficiently develop new vaccinations.

Eppendorf, your expert partner in bioprocessing, contributes with its bioprocess solutions and services.

A narrow residence time distribution (RTD) is highly desirable for continuous processes where a strict incubation time must be ensured, such as continuous virus inactivation. A narrow RTD also results in faster startup and shut down phases and limits the broadening of potential disturbances in continuous processes. A packed bed reactor with non-porous inert beads was developed to achieve narrow RTDs.

In January 2020, China saw an outbreak of a new coronavirus strain now named SARS-CoV-2. Although the animal reservoir for the SARS and MERS viruses are known, this has yet to have been confirmed for SARS-CoV-2. All three strains are transmissible between humans.

To allow the widest possible distribution of relevant research, the Microbiology Society has brought together articles from across our portfolio and made this content freely available until further notice.

This meeting aims to showcase vignettes of modern medicinal chemistry to bring new thinking to the subject, challenge perceptions and encourage scientific interaction between researchers. The short presentation format of the meeting also aims to provide a focussed forum to promote examples of medicinal chemistry excellence.